Unlabelled: This national study found that remote therapeutic monitoring use increased rapidly between 2022 and 2024 but remained low overall, varied by insurance type and clinician specialty, and was concentrated among patients with musculoskeletal conditions.
No takes yet. Share an insight, caveat, or question.
Joo et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: